The application relates to biometric authentication using vein patterns of e.g. a palm or a finger. The positions of the vein pattern for matching are normally defined in respect of the outline of the considered region, which requires the acquisition of the entire region. For speed reasons it is desired to perform vein authentication using partial patterns.
CASELAW-EPO - reviews of EPO Boards of Appeal decisions
T 1246/21 – Assessing IS = more than just combining documents – Common general knowledge also plays a role
The present invention generally relates to an optical system for projecting one or more synthetic optical images, which demonstrates improved resistance to optically degrading external effects.
Brief outline of the case
The proprietor appealed the revocation of its patent.
The board confirmed that claim 1 as granted contravened Art 123(2)
Admissible AR were not allowable,
T 451/20 – Do not wait for the opinion of the board in order to file requests – No features from the description
The patent relates generally to agents and devices for promoting haemostasis and tissue sealing materials and, more particularly, to synthetic peptides having strong haemostatic properties and tissue sealing properties in combination with scaffolds, such as gelatine based haemostatic scaffolds.
Brief outline of the case
The patent was maintained according to AR 4 by the OD.
T 681/21 – On the application of G 2/21 in case of a later alleged synergy effect
The patent relates to a fabric treatment composition, exactly to a softener.
Brief outline of the case
Opponent 2 appealed the decision to reject the opposition.
In appeal there was a long discussion about experimental data submitted by all the parties. Those data were all post-published.
There was unanimity among the parties that D1=DE 10 2006 034 051,
T 728/21 – G 2/21 also applies when it comes to sufficiency
The patent relates to a “Tablet formulation of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cystic fibrosis”.
Brief outline of the case
The OD decided maintenance according to AR 16 as the claims as granted and AR 1-15 where lacking sufficiency.
The opponent appealed the decision of the OD.